Fellowship Applications close 11:59pm 30th JuneDon't miss your opportunity to apply! NCCRED has developed a multidisciplinary mentoring and training program. Fellows can be of any multidisciplinary background (e.g. Nursing, Allied Health, Medical), and fellowships will be open to practising clinicians in the Alcohol and Other Drugs sector. Key Dates Applications open: 15 May 19 Applications close: 30 Jun 19 Applications reviewed: 3 Jul 19 Interview period: 03-10 Jul 19 NCCRED Board reviews recommendations: 11 Jul 19 Acceptance Notification: 15 Jul 19 Deadline for Acceptance: 25 Jul 19 Fellowship Begins: 1 Feb 20 (rolling not fixed) Are you going to APSAD?Don't miss the NCCRED Symposium which is being held as part of APSAD on Sunday 10th November 2019 in Hobart at the Hotel Grand Chancellor Hobart. Registrations are now open, follow the link below Please note if you register for the NCCRED Symposium you will still need to register for the APSAD conference Round 3 Grant Applications are now open!NCCRED is releasing Grants to fund innovative Clinical Research for the treatment of substance use disorder due to methamphetamine or emerging drugs of concern.$500,000 is available in Round 3 of funding! Applications close on 30th July. Key Dates Applications open: 15 May 19 Applications close: 30 Jul 19 Applications reviewed: 04 Sep 19 NCCRED Board awards funding: 26 Sep 19 Applicants are notified of results: 1 Oct 19 Final study report due to NCCRED: 1 Apr 2021 FundingThis funding will provide financial support as a seed-funding grant to establish investigator-initiated research. Grant applications will be reviewed by the independent NCCRED Methamphetamine and Emerging Drugs Working Group and presented to the NCCRED Board for support of funding. For more information on the Grants funding process, to access the guidelines and application form or to contact us with any questions, please follow the link below. Upcoming Supported EventsBelow is a list of events for NCCRED supported organisations. The National Centre for Clinical Research on Emerging Drugs is made up of a consortium of the following four institutions |